SynopsisThe global Bipolar Forceps market size was US$ 825 million in 2024 and is forecast to a readjusted size of US$ 1053 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031. Bipolar forceps are a revolutionary instrument designed for pro.....
SynopsisThe global market for Lamivudine API was valued at US$ 61.3 million in the year 2024 and is projected to reach a revised size of US$ 78.7 million by 2031, growing at a CAGR of 4.4% during the forecast period. Lamivudine API (Active Pharmaceutical Ingredi.....
SynopsisThe global Cytotoxic Drug market size was US$ 15000 million in 2024 and is forecast to a readjusted size of US$ 16180 million by 2031 with a CAGR of 1.1% during the forecast period 2025-2031. Cytotoxic drugs inhibit or prevent the function of cells. Cyt.....
SynopsisThe global Glucagon Like Peptide-1 (GLP-1) Agonists market size was US$ 108120 million in 2024 and is forecast to a readjusted size of US$ 490060 million by 2031 with a CAGR of 24.5% during the forecast period 2025-2031. Glucagon like peptide-1 (GLP-1) .....
SynopsisThe global Helium-neon Laser Film market size was US$ 153 million in 2024 and is forecast to a readjusted size of US$ 100 million by 2031 with a CAGR of -6.0% during the forecast period 2025-2031. Helium-neon laser film features a red sensitivity at 633.....
SynopsisThe global market for Capsule Endoscopy Devices was valued at US$ 444 million in the year 2024 and is projected to reach a revised size of US$ 756 million by 2031, growing at a CAGR of 7.9% during the forecast period. A capsule endoscopy device is a smal.....
SynopsisThe global market for Coronary Artery Bypass Grafts (CABG) was valued at US$ 142 million in the year 2024 and is projected to reach a revised size of US$ 202 million by 2031, growing at a CAGR of 5.2% during the forecast period. Coronary artery bypass su.....
SynopsisThe global Hemostatic Agents market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031. Hemostatic agents are used as an adjunct or alternative to standard suturi.....
SynopsisThe global ENT Devices market size was US$ 20120 million in 2024 and is forecast to a readjusted size of US$ 29530 million by 2031 with a CAGR of 5.7% during the forecast period 2025-2031. ENT devices, which include the diagnostic devices, surgical devi.....
SynopsisThe global market for Overactive Bladder Non-Pharmacological Treatment was valued at US$ 1500 million in the year 2024 and is projected to reach a revised size of US$ 2248 million by 2031, growing at a CAGR of 5.9% during the forecast period. Overactive .....
